Long Island Vitreoretinal Consultants (01-013) — Westbury, New York

Long Island Vitreoretinal Consultants (01-013) is a clinical research site located in Westbury, New York, United States 11590.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Long Island Vitreoretinal Consultants (01-013) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Geographic Atrophy.

Sponsors: Apellis Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Long Island Vitreoretinal Consultants (01-013)?

Long Island Vitreoretinal Consultants (01-013) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Long Island Vitreoretinal Consultants (01-013) conducted?

Long Island Vitreoretinal Consultants (01-013) has 1 clinical trials on record, with 1 currently active. Their work covers Geographic Atrophy.

Is Long Island Vitreoretinal Consultants (01-013) accredited by Crixeo Health?

Long Island Vitreoretinal Consultants (01-013) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Long Island Vitreoretinal Consultants (01-013)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.